Add to watchlist
$239.85
Last updated:06/15/2021
AMGN: NASDAQ
Amgen Inc

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoi… Show more

Dividend yield
2.80%
$6.72 anually

3y growth is 10.1%– Yield is 25% higher than average in Health Care sector

P/E ratio
19.87x
vs. 14.86x forward

Price is 19.87x times more than EPS $12.07 which eaquals $239.85

Payout ratio
55.66%
Yearly

55.66% of earnings is used as dividends.

CASH payout ratio

Last quarter

Become our supporter to unlock all data!
Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
AMGN dividends
Payout frequency
Quarterly
Latest ex-date
05/14/2021
3y growth
10.1%
5y growth
12.43%
$1.32
$1.32
02/14/2018
$1.32
$1.32
05/16/2018
$1.32
$1.32
08/16/2018
$1.32
$1.32
11/15/2018
2018
$5.28
$1.45
$1.45
02/14/2019
$1.45
$1.45
05/16/2019
$1.45
$1.45
08/14/2019
$1.45
$1.45
11/14/2019
2019
$5.8
$1.6
$1.6
02/13/2020
$1.6
$1.6
05/15/2020
$1.6
$1.6
08/14/2020
$1.6
$1.6
11/13/2020
2020
$6.4
$1.76
$1.76
02/11/2021
$1.76
$1.76
05/14/2021
2021
So far
$3.52
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
1.979B
8.394B
+324.15%
7.842B
-6.58%
7.264B
-7.37%
Cashflow
Sum up money going in and out company
11.177B
11.296B
+1.06%
9.15B
-19.00%
10.497B
+14.72%
Total liabilities
All combined debts and obligations
54.713B
53.916B
-1.46%
50.034B
-7.20%
53.539B
+7.01%
Stock exposure in ETFs
ETF
Percentage of ETF
Become a premium member and see all 57 ETFs that include this stock
Company profile
CEO
Mr. Robert A. Bradway
Market capitalization
Mega (137.81B)
AMGN price history
Loading price stock history...